Home Tech Dow Rebounds as Apple Rallies Into Earnings By Investing.com

Dow Rebounds as Apple Rallies Into Earnings By Investing.com

56
0
Shares- Trade Anxieties Drag Industry Lower By Investing.com
Shares- Trade Anxieties Drag Industry Lower By Investing.com


© Reuters.

By Yasin Ebrahim

Investing.com – The rallied sharply Tuesday, as the rout a day earlier attracted bargain buying across stocks, even as the bulk of corporate earnings failed to live up to Wall Street expectations.

The rose 1%, while the gained 1.4% and the rose 0.7%.

Bargain-hunting investors piled into beaten-down sectors like tech and travel stocks.

American Airlines (NASDAQ:) and Delta Air Lines (NYSE:) both ended in a day the green. But United Airlines (NASDAQ:) proved an expectation to the rally after announcing that it was cutting some flights from the U.S. to mainland China, citing a “significant decline in demand as the (coronavirus) continues to spread.”

The death toll from the coronavirus in China rose to 106, with 4,600 affected globally, according to media reports.

Tech also saw some reprieve, led by a rebound in semiconductor stocks with some on Wall Street suggesting the outbreak may pose a benefit to U.S.-based chip firms.

Any disruption to memory output in China on the back of a faster spread of the virus could “be positive for memory suppliers outside of China such as Micron (NASDAQ:), Western Digital (NASDAQ:) and others,” said Mizuho analyst Vijay Rakesh.

The ended the day more than 2% higher.

Apple (NASDAQ:) also supported the rally in the broader market, rising nearly 3% ahead of its fiscal first-quarter report due after the closing bell.

A wave of mostly bearish earnings, meanwhile, had little impact on sentiment.

3M (NYSE:) slipped about 6% after the industrial giant reported that fell short of Wall Street estimates. United Technologies (NYSE:), however, beat quarterly estimates on both the , sending its shares about 1% higher.

Pfizer (NYSE:), meanwhile, fell 5% after its estimates, driven partly by the loss of exclusivity for its pain drug Lyrica.

Sentiment on stocks was also underpinned by bullish economic data showing a sharp rise in consumer confidence.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here